Keyphrases
Relapsing-remitting multiple Sclerosis
100%
Multiple Sclerosis
100%
Monoclonal Antibody
100%
Disease-modifying Therapy
66%
Therapeutic Monoclonal Antibody
66%
Multiple Sclerosis Treatment
66%
Clinical Research
33%
High Efficacy
33%
Autoimmune Pathology
33%
Treatment Strategy
33%
Biotechnological Advances
33%
Pharmaceutical Compounds
33%
Increased Safety
33%
Mode of Action
33%
Safety Profile
33%
Acceptable Safety
33%
Disease Course
33%
Safety Efficacy
33%
Neurological Impairment
33%
Emerging Therapeutics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
Multiple Sclerosis
100%
Diseases
33%
Autoimmune Disease
16%
Disease Course
16%
Demyelination
16%
Clinical Research
16%
Neuroscience
Monoclonal Antibody
100%
Multiple Sclerosis
100%
Treatment of Multiple Sclerosis
50%
Central Nervous System
25%
Autoimmune Disease
25%
Immunology and Microbiology
Multiple Sclerosis
100%
Monoclonal Antibody
100%
Treatment of Multiple Sclerosis
50%
Autoimmune Disease
25%
Central Nervous System
25%